News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Endo Pharmaceuticals (ENDP) Grants Valeant Pharmaceuticals International (VRX) License to Market Pain Drug



6/9/2009 7:21:10 AM

Bookmark and Share

Reuters -- Endo Pharmaceuticals Holdings Inc has granted Valeant Pharmaceuticals International an exclusive license to market the pain drug Opana in Canada, Australia and New Zealand for an upfront payment of C$2 million ($1.8 million), the companies said.


Read at Reuters
Read at Forbes


comments powered by Disqus
Reuters
Forbes
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES